Delhi High Court Permanently Restrains Pharmaceutical Products Manufacturers From Using LOOZOUT Trademark, Imposes Rs. 2 Lakhs Cost
Nupur Thapliyal
24 Jun 2022 12:45 PM IST

Next Story
24 Jun 2022 12:45 PM IST
The Delhi High Court has permanently restrained two manufacturers of the pharmaceutical products from manufacturing, selling, advertising and promoting the products using the trademark 'LOOZOUT', which was deceptively similar to the registered trademark 'LOOZ'. Justice Jyoti Singh also restrained the manufacturers from manufacturing and selling products under any other mark which was identical...
Your support helps us to bring you more content at
an affordable subscription scheme !!!
All payment options available
Nupur Thapliyal is a Principal Correspondent with LiveLaw, based in New Delhi. She reports from the Delhi High Court and trial courts in the national capital
